These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8186951)

  • 61. Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.
    Takeda A; Arai N; Komori T; Iseki E; Kato S; Oda M
    Neurosci Lett; 1997 Sep; 234(1):63-6. PubMed ID: 9347947
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiple system atrophy (MSA) with massive macrophage infiltration in the ponto-cerebellar afferent system.
    Yokoyama T; Hasegawa K; Horiuchi E; Yagishita S
    Neuropathology; 2007 Aug; 27(4):375-7. PubMed ID: 17899692
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Is cranial computerized tomography useful in the diagnosis of multiple system atrophy?
    Wenning GK; Jäger R; Kendall B; Kingsley D; Daniel SE; Quinn NP
    Mov Disord; 1994 May; 9(3):333-6. PubMed ID: 8041375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [High-field MR findings of multiple system atrophy].
    Tsuchiya K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):772-9. PubMed ID: 2235325
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Neuronal kinases in glial cytoplasmic inclusions in patients with multiple system atrophy].
    Nakamura S; Kawamoto Y; Nakano S; Akguchi I; Kimura J
    Rinsho Shinkeigaku; 1999 Jan; 39(1):13-5. PubMed ID: 10377787
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunohistochemical and Molecular Investigations Show Alteration in the Inflammatory Profile of Multiple System Atrophy Brain.
    Kiely AP; Murray CE; Foti SC; Benson BC; Courtney R; Strand C; Lashley T; Holton JL
    J Neuropathol Exp Neurol; 2018 Jul; 77(7):598-607. PubMed ID: 29850876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hereditary neuronal intranuclear inclusion disease with autonomic failure and cerebellar degeneration.
    Zannolli R; Gilman S; Rossi S; Volpi N; Bernini A; Galluzzi P; Galimberti D; Pucci L; D'Ambrosio A; Morgese G; Giannini F
    Arch Neurol; 2002 Aug; 59(8):1319-26. PubMed ID: 12164731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
    Wenning GK; Ben Shlomo Y; Magalhães M; Daniel SE; Quinn NP
    Brain; 1994 Aug; 117 ( Pt 4)():835-45. PubMed ID: 7922469
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expanding the spectrum of neuronal pathology in multiple system atrophy.
    Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
    Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Neuropathological background of spinocerebellar degeneration--with special reference to autonomic nervous system lesions in olivopontocerebellar atrophy, Shy-Drager syndrome and multiple system atrophy].
    Mizutani T
    No To Shinkei; 1985 Jul; 37(7):675-85. PubMed ID: 4063122
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy.
    Chiba Y; Takei S; Kawamura N; Kawaguchi Y; Sasaki K; Hasegawa-Ishii S; Furukawa A; Hosokawa M; Shimada A
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):559-71. PubMed ID: 22013984
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-DARPP32 antibody-immunopositive inclusions in the brain of patients with multiple system atrophy.
    Honjo Y; Shirakashi Y; Kawamoto Y; Akiguchi I
    Clin Neuropathol; 2008; 27(5):309-16. PubMed ID: 18808062
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Frequent globular neuronal cytoplasmic inclusions in the medial temporal region as a possible characteristic feature in multiple system atrophy with dementia.
    Homma T; Mochizuki Y; Komori T; Isozaki E
    Neuropathology; 2016 Oct; 36(5):421-431. PubMed ID: 26970514
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
    Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
    Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Striato-nigral degeneration (SND): a multisystem atrophy?].
    Bergmann M; Schmidtke K; Danek A; Gullotta F; Mehraein P
    Schweiz Arch Neurol Psychiatr (1985); 1990; 141(5):389-405. PubMed ID: 1701267
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis.
    Fellner L; Buchinger E; Brueck D; Irschick R; Wenning GK; Stefanova N
    BMC Neurosci; 2018 May; 19(1):32. PubMed ID: 29783943
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: A quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system).
    Ishizawa K; Komori T; Arai N; Mizutani T; Hirose T
    Neuropathology; 2008 Jun; 28(3):249-57. PubMed ID: 18312549
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Parkinsonism. Multiple system atrophy.
    Wenning GK; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):187-204. PubMed ID: 9426875
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Diagnosis and therapy of multiple system atrophy].
    Wenning GK; Seppi K
    Praxis (Bern 1994); 2001 Jun; 90(23):1035-40. PubMed ID: 11447723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. XIAP immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.
    Kawamoto Y; Ito H; Ihara M; Takahashi R
    Clin Neuropathol; 2014; 33(1):76-83. PubMed ID: 23993308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.